Mar. 23 -- WEDNESDAY, Aug. 15 (HealthDay News) -- For the first time, scientists say they have identified an immune molecule that may predict prostate cancer recurrence after surgery. "We discovered a ...
The role of adjuvant chemotherapy in stage II colon cancer continues to be debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor recurrence-free survival, whereas its ...
European scientists have announced their success in developing a breakthrough drug that prevents the spread and recurrence of human breast cancer in lab mice, as well as success in human patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback